217F3: Medtronic Freezor Xtra Cardiac Cryoablation Catheter, Medium/Blue, 6mm Tip, 7F x 108cm, 55mm Reach

In-Date » Medtronic Vascular » Ablation | Cryo

Medtronic Freezor Cardiac Cryoablation Catheter

The Freezor™ cardiac cryoablation catheters are single-use catheters designed to ablate cardiac tissue by creating focal lesions. The Freezor™ and Freezor™ Xtra catheters are designed for the treatment of atrioventricular nodal reentry tachycardia (AVNRT). The Freezor™ MAX catheter is designed for the treatment of atrial fibrillation.

Freezor™ and Freezor™ Xtra cardiac cryoablation catheters freeze the target tissue and block the electrical conduction by creating scar tissue. The catheters are designed to create focal lesions to treat (AVNRT) for both adult and pediatric† patients.

The Freezor™ Xtra catheter is also intended for minimally invasive cardiac surgery procedures, including surgical treatment of cardiac arrhythmias.

Product Code: 217F3

• Description: Medium/Blue
• Tip Length: 6mm
• Electrode Spacing: 2.5mm-5mm-2.5mm
• Catheter Diameter: 7F
• Shaft Length: 108cm
• Recommended Introducer: 8F
• Reach: 55mm

Freezor™ Xtra Cardiac Cryoablation Catheter Product Options

• 217F1: Short/Red, 49mm Reach
• 217F3: Medium/Blue, 55mm Reach
• 217F5: Long/Orange, 60mm Reach

Sterilization

• Device Packaged as Sterile: Yes
• Requires Sterilization Prior to Use: No 
• Single-Use
• Disposable

Additional Details

• Company Name: Medtronic, Inc.
• FDA Product Code: LPB
• FDA Product Code Name: Cardiac Ablation Percutaneous Catheter
• GMDN Term Code: 60720
• GMDN Term Name: Cardiac cryosurgical system catheter
• GMDN Term Definition: A sterile, flexible device intended to be used as part of a cardiac tissue cryosurgical system to cryogenically ablate areas of the endocardium of a beating heart in the treatment of cardiac arrhythmias. It is intended to be introduced into the heart via venous access (e.g., femoral vein) and deliver pressurized liquid refrigerant (e.g., nitrous oxide) to its distal cooling segment to achieve extremely low temperatures through gas expansion; it typically includes sensors (e.g., temperature monitoring). This is a single-use device.

Cryoablation is a catheter-based technique used to treat atrial fibrillation by applying extreme cold to targeted areas of heart tissue. This freezing process creates scar tissue that blocks the abnormal electrical signals responsible for triggering arrhythmia. Unlike heat-based methods like radiofrequency ablation, cryoablation uses a balloon catheter to deliver cold energy in a more uniform, circumferential manner—often around the pulmonary veins. The approach is valued for its procedural consistency, controlled lesion formation, and lower risk of certain complications, making it a widely used option in the treatment of AF.

Medtronic Cardiovascular Therapies offers a broad range of solutions for treating peripheral artery disease, aortic aneurysms, deep vein thrombosis, and other vascular conditions. Key technologies include the Endurant II and Endurant IIs stent graft systems for abdominal aortic aneurysms, the IN.PACT Admiral drug-coated balloon for femoropopliteal disease, and the Abre venous self-expanding stent system for iliofemoral venous outflow obstruction. With a commitment to advancing minimally invasive therapies, Medtronic’s vascular innovations help restore blood flow, reduce procedural risk, and improve quality of life for patients with complex vascular disease.

There is no valid manufacturer warranty on the products that Synergy Surgical sells. Any services provided by the original manufacturer of the products we sell are not available.  However, eSutures offers a 100% money back guarantee (less shipping) on every item we sell within 30 days of purchase. For details, please see our Return Policy.